These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Home hemodialysis, daily hemodialysis, and nocturnal hemodialysis: Core Curriculum 2009. Perl J; Chan CT Am J Kidney Dis; 2009 Dec; 54(6):1171-84. PubMed ID: 19748715 [No Abstract] [Full Text] [Related]
4. The cost of starting and maintaining a large home hemodialysis program. Komenda P; Copland M; Makwana J; Djurdjev O; Sood MM; Levin A Kidney Int; 2010 Jun; 77(11):1039-45. PubMed ID: 20375983 [TBL] [Abstract][Full Text] [Related]
5. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Mowatt G; Vale L; Perez J; Wyness L; Fraser C; MacLeod A; Daly C; Stearns SC Health Technol Assess; 2003; 7(2):1-174. PubMed ID: 12773260 [No Abstract] [Full Text] [Related]
6. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis. Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781 [TBL] [Abstract][Full Text] [Related]
11. Dialysis: Nocturnal hemodialysis--should we still provide this therapy? Kerr PG Nat Rev Nephrol; 2011 Sep; 7(11):611-2. PubMed ID: 21931336 [No Abstract] [Full Text] [Related]
12. What we learn from studies on more frequent dialysis. Miller B Nephrol News Issues; 2011 Nov; 25(12):14, 16. PubMed ID: 22204162 [No Abstract] [Full Text] [Related]
13. An operating cost comparison between conventional and home quotidian hemodialysis. Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444 [TBL] [Abstract][Full Text] [Related]
14. Health economic evaluations: the special case of end-stage renal disease treatment. Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484 [TBL] [Abstract][Full Text] [Related]
15. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy. Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528 [TBL] [Abstract][Full Text] [Related]
16. Daily nocturnal home hemodialysis. Pierratos A Kidney Int; 2004 May; 65(5):1975-86. PubMed ID: 15086951 [No Abstract] [Full Text] [Related]
17. The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia. Faratro R; D'Gama C; Chan C CANNT J; 2008; 18(4):32-5. PubMed ID: 19175190 [TBL] [Abstract][Full Text] [Related]
18. Making peritoneal dialysis and home hemodialysis more economically viable. Sullivan JD Nephrol News Issues; 2006 Jul; 20(8):54, 56-8. PubMed ID: 16859233 [No Abstract] [Full Text] [Related]
20. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA Kidney Int; 2003 Sep; 64(3):1004-11. PubMed ID: 12911550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]